This study highlights plasma S100β as a promising non-invasive biomarker for early detection and progression monitoring of Alzheimer’s disease. Given its strong association with cognitive decline and AD pathology, S100β could serve as a valuable diagnostic tool, addressing the urgent need for accessible biomarkers to guide early interventions and treatment strategies.

Valerie awarded the Lyman T. Johnson Fellowship
Valerie has been selected for the University of Kentucky Graduate School Lyman T. Johnson Fellowship. This fellowship was named in honor of Lyman T. Johnson and recognizes incoming graduate students and supports their graduate training. The award reflects Valerie’s strong academic record and potential for impactful scholarship. Congratulations, Valerie!


